TTR and familial amyloid neuropathy: In recent years, it has been shown that tolcapone is a potent inhibitor of the amyloid aggregation process of the transthyretin protein, and acts through stabilizing the structure of the protein, reducing the progression of a disease called familial amyloid polyneuropathy [16].